Target intelligence / Profile preview

Neuronal nicotinic acetylcholine receptor (nAChR)

Target
nAChR
Molecular classification
ligand-gated ion channel, pentameric protein, cation-selective channel
01

Overview

Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that respond to the neurotransmitter acetylcholine and are also targeted by the addictive drug nicotine. They play crucial roles in neuronal communication by converting neurotransmitter binding into membrane electrical depolarization. Neuronal nAChRs are pentameric proteins composed of five subunits (α2-α7, α9, α10, β2-β4) arranged symmetrically around a central water-filled pore. These subunits form various combinations, creating diverse receptor subtypes, such as α4β2 heteromeric receptors (high affinity for nicotine) and α7 homomeric receptors (main contributor to α-bungarotoxin-binding sites). α4β2 receptors can exist in different stoichiometries, contributing to functional diversity and modulation. Neuronal nAChRs mediate fast neurotransmission, function as cation-selective channels allowing passage of Na+, K+, and sometimes Ca2+. Acetylcholine binding triggers rapid channel opening and membrane depolarization, followed by desensitization. They regulate neurotransmitter release, cell excitability, neuronal integration, and contribute to synaptic plasticity, learning, memory, attention, and cognitive functions. Pathologically, they are implicated in nicotine addiction, neurodegenerative disorders (e.g., Alzheimer's), pain processing, and inflammatory conditions. Neuronal nAChRs represent important therapeutic targets for conditions like pain (e.g., α4β2 agonists like ABT-594), Alzheimer's disease, and addiction. However, therapeutic development is challenging due to side effects, highlighting the need for selective compounds. They interact with endogenous ligands (acetylcholine), exogenous substances (nicotine), toxins, and inflammatory mediators.

Other names
neuronal nAChRs
02

Mechanism of action

Ligand-gated ion channels that open upon binding of acetylcholine or agonists, allowing the influx of cations (Na+, K+, Ca2+) and causing membrane depolarization. Targeting typically involves agonists or modulators to enhance channel activity.

03

Biological functions

Neuronal communicationConversion of neurotransmitter binding into membrane electrical depolarizationFast neurotransmissionPassage of Na+, K+, and Ca2+ ionsRapid channel opening upon acetylcholine bindingMembrane depolarizationDesensitizationRegulation of neurotransmitter releaseCell excitability modulationNeuronal integrationSynaptic plasticity (e.g., LTP)Learning and memory processesAttention and cognitive functions
04

Disease associations

Nicotine addictionSubstance abuseNeurodegenerative disorders (e.g., Alzheimer's disease)Pain processingNociceptionInflammatory conditions
05

Safety considerations

Side effectsNeed for selectivityTherapeutic challenges in drug development
06

Interacting drugs

Acetylcholine (endogenous ligand)

5 more in the full profile.

Beyond the preview

Go deeper on Neuronal nicotinic acetylcholine receptor (nAChR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal nicotinic acetylcholine receptor (nAChR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call